| Alpha emitter radium-223 and survival in metastatic prostate cancer C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fosså, ... New England Journal of Medicine 369 (3), 213-223, 2013 | 3655 | 2013 |
| Abiraterone for prostate cancer not previously treated with hormone therapy ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ... New England Journal of Medicine 377 (4), 338-351, 2017 | 1730 | 2017 |
| The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial START Trialists' Group The Lancet 371 (9618), 1098-1107, 2008 | 1462 | 2008 |
| Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline S Lutz, L Berk, E Chang, E Chow, C Hahn, P Hoskin, D Howell, A Konski, ... International Journal of Radiation Oncology* Biology* Physics 79 (4), 965-976, 2011 | 1007 | 2011 |
| Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ... European urology 59 (4), 477-494, 2011 | 881 | 2011 |
| Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma J Radford, T Illidge, N Counsell, B Hancock, R Pettengell, P Johnson, ... New England Journal of Medicine 372 (17), 1598-1607, 2015 | 788 | 2015 |
| Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines M Fallon, R Giusti, F Aielli, P Hoskin, R Rolke, M Sharma, CI Ripamonti Annals of Oncology 29, iv166-iv191, 2018 | 731 | 2018 |
| Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study A Sturdza, R Pötter, LU Fokdal, C Haie-Meder, LT Tan, R Mazeron, ... Radiotherapy and Oncology 120 (3), 428-433, 2016 | 656 | 2016 |
| Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial KM Ardeshna, P Smith, A Norton, BW Hancock, PJ Hoskin, ... The Lancet 362 (9383), 516-522, 2003 | 653 | 2003 |
| Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer PJ Hoskin, AM Rojas, PJ Bownes, GJ Lowe, PJ Ostler, L Bryant Radiotherapy and Oncology 103 (2), 217-222, 2012 | 569 | 2012 |
| Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases P Price, PJ Hoskin, D Easton, D Austin, SG Palmer, JR Yarnold Radiotherapy and Oncology 6 (4), 247-255, 1986 | 567 | 1986 |
| Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre … SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... The lancet oncology 19 (3), 295-309, 2018 | 557 | 2018 |
| Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind … O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ... The Lancet Oncology 15 (7), 738-746, 2014 | 552 | 2014 |
| The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies R Pötter, K Tanderup, C Kirisits, A de Leeuw, K Kirchheiner, R Nout, ... Clinical and translational radiation oncology 9, 48-60, 2018 | 541 | 2018 |
| Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study AJ Swerdlow, CD Higgins, P Smith, D Cunningham, BW Hancock, ... Journal of the National Cancer Institute 99 (3), 206-214, 2007 | 526 | 2007 |
| Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019) ND James, MR Spears, NW Clarke, DP Dearnaley, JS De Bono, J Gale, ... European urology 67 (6), 1028-1038, 2015 | 509 | 2015 |
| Non–small cell lung cancer: histopathologic correlates for texture parameters at CT B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles Radiology 266 (1), 326-336, 2013 | 483 | 2013 |
| Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a … P Hoskin, O Sartor, JM O'Sullivan, DC Johannessen, SI Helle, J Logue, ... The Lancet Oncology 15 (12), 1397-1406, 2014 | 480 | 2014 |
| Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression D Rades, LJA Stalpers, T Veninga, R Schulte, PJ Hoskin, N Obralic, ... Journal of Clinical Oncology 23 (15), 3366-3375, 2005 | 412 | 2005 |
| Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer O Sartor, RH Reid, PJ Hoskin, DP Quick, PJ Ell, RE Coleman, JA Kotler, ... Urology 63 (5), 940-945, 2004 | 404 | 2004 |
